Association of anti-diabetic drugs and COVID-19 outcomes in patients with diabetes mellitus type 2 and cardiomyopathy

Association of anti-diabetic drugs and COVID-19 outcomes in patients with diabetes mellitus type 2 and cardiomyopathy

Abstract There is a scarcity of information on the population with diabetes mellitus type 2 and cardiomyopathy (PDMC) in COVID-19, especially on the association between anti-diabetic medications and COVID-19 outcomes. Study is designed as a retrospective cohort analysis covering 2020 and 2021. Data...

Full description

Bibliographic Details
Main Authors: Jelena Dimnjaković, Tamara Buble, Pero Ivanko, Ivan Pristaš, Ognjen Brborović, Hana Brborović
Format: Article
Language:English
Published: Nature Portfolio 2024-03-01
Series:Scientific Reports
Subjects:
Diabetes mellitus type 2
COVID-19
Hypoglycemic agents
Sodium-glucose transporter 2 inhibitors
Insulin
Dipeptidyl-peptidase 4 inhibitors
Online Access:https://doi.org/10.1038/s41598-024-57871-9

Internet

https://doi.org/10.1038/s41598-024-57871-9

Similar Items